An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target Frontiers
Iranian scientists explore drug repurposing to tackle endometriosis TV BRICS
Endometriosis, a benign gynecological disorder affecting 10-15% of women during their reproductive years, is characterized by the growth of endometrial tissue outside the uterus. Despite its prevalence, the exact pathophysiology …
This study advances sustainable pharmaceutical research for endometriosis by developing in vitro 3D cell culture models of endometriotic pathophysiology that allow antifibrotic drug candidates to be tested. Fibrosis is a …
Hong Kong unveils novel therapeutic targets and drug repurposing opportunities for endometriosis BSA bureau
Endometriosis affects over 190 million women globally, and effective therapies are urgently needed to address the burden of endometriosis on women's health. Using an artificial intelligence (AI)-driven target discovery platform, …